摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-tetra-O-acetyl-β-D-glucopyranosyl isocyanodichloride | 104910-44-3

中文名称
——
中文别名
——
英文名称
N-tetra-O-acetyl-β-D-glucopyranosyl isocyanodichloride
英文别名
[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(dichloromethylideneamino)oxan-2-yl]methyl acetate
N-tetra-O-acetyl-β-D-glucopyranosyl isocyanodichloride化学式
CAS
104910-44-3
化学式
C15H19Cl2NO9
mdl
——
分子量
428.223
InChiKey
CBWANCLXFDLWMM-RKQHYHRCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    27.0
  • 可旋转键数:
    6.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    126.79
  • 氢给体数:
    0.0
  • 氢受体数:
    10.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-tetra-O-acetyl-β-D-glucopyranosyl isocyanodichloride 在 sodium azide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 0.5h, 以60%的产率得到[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(5-chlorotetrazol-1-yl)oxan-2-yl]methyl acetate
    参考文献:
    名称:
    Hassel, Tillmann; Mueller, Hanns Peter, Angewandte Chemie, 1987, vol. 99, # 4, p. 368 - 369
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    通过碳-硫键形成合成和表征 N-葡萄糖基化的二硫二氮杂衍生物
    摘要:
    摘要 通过 N-四-O-乙酰基-β-d 反应合成了新型 4,7-双(芳氨基)-2-四-O-乙酰基-β-d-吡喃葡萄糖基亚氨基-1,3,5,6-二硫氮杂-吡喃葡萄糖基异氰二氯化物与 1,6-二芳基-2,5-二硫代-双-脲,不使用任何催化剂。因此,探索了通过碳硫键形成合成含有两个硫和两个氮原子的 7 元杂环。这些新化合物的化学结构通过 IR、1H NMR、13C NMR、质谱和元素分析得到阐明。
    DOI:
    10.1515/hc-2015-0093
点击查看最新优质反应信息

文献信息

  • Synthesis and Molecular Docking Studies of Glucose-linked Isonicotinoyl- 1,3,4-Thiadiazolidines as Antitubercular Agents
    作者:Snehal A. Chavan、Avinash G. Ulhe、Baliram N. Berad、Rupesh V. Chikhale
    DOI:10.2174/1570178614666170608130326
    日期:2017.12.11
    Background: The recent emergence of multidrug-resistant strains of M. tuberculosis that are resistant to two major effective drugs, viz. isoniazid and rifampicin, stimulated us to make an attempt for the development of a new class of potent antitubercular agents by modifying the structures of existing drugs. Aiming this, an efficient synthesis of glucose linked-isonicotinoyl-1,3,4-thiadiazolidines has been carried out. Method: The title compounds have been synthesized through cyclocondensation reaction of 1- isonicotinoyl-4-aryl thiosemicarbazides with N-tetra-O-acetyl-β-D-glucopyranosyl isocyanodichloride. The structures of newly synthesized compounds were verified by IR, 1H NMR, 13C NMR, mass spectrometry and elemental analyses. The title compounds were evaluated for their in vitro antitubercular potency against M. tuberculosis H37Rv strain using Lowenstein-Jensen method. Results: A few title compounds were found to be equipotent with the reference drug rifampicin, while moderately potent, when compared with the reference drug isoniazid. These compounds were subjected to molecular docking studies and their results were found to be in agreement with the in vitro studies. Conclusion: We reported simple and efficient protocol for the synthesis of series of bioactive glucoselinked isonicotinoyl-1,3,4-thiadiazolidines by utilizing N-tetra-O-acetyl-β-D-glucopyranosyl isocyanodichloride as a suitable reagent for glycosylation. This approach is a valuable addition to the fastdeveloping field of glucose-linked heterocycles and might be used to develop new potential drugs. We demonstrated the introduction of isonicotinoyl and glucosyl moieties in single molecular framework which may prove beneficial for developing new class of antitubercular agents.
    背景:最近出现了对异烟利福平这两种主要有效药物具有耐药性的结核杆菌耐多药菌株,这促使我们尝试通过改变现有药物的结构来开发一类新的强效抗结核药物。为此,我们进行了葡萄糖连接异烟酰基-1,3,4-噻二唑烷的高效合成。 方法:通过 1-异烟酰基-4-芳基氨基甲酸与 N-四-O-乙酰基-β-D-吡喃葡萄糖基异基二的环缩合反应合成了标题化合物。 通过红外光谱、1H NMR、13C NMR、质谱和元素分析验证了新合成化合物的结构。采用 Lowenstein-Jensen 方法评估了标题化合物对结核杆菌 H37Rv 株的体外抗结核效力。 结果:发现一些标题化合物与参比药物利福平的效力相当,而与参比药物异烟相比,效力适中。对这些化合物进行了分子对接研究,发现其结果与体外研究结果一致。 结论:我们报道了利用 N-四-O-乙酰基-β-D-吡喃葡萄糖基异基二化物作为糖基化的合适试剂,合成一系列具有生物活性的葡萄糖苷联异烟酰基-1,3,4-噻二唑烷的简单而有效的方法。这种方法是对快速发展的葡萄糖连接杂环领域的宝贵补充,可用于开发新的潜在药物。我们展示了在单一分子框架中引入异烟酰基和葡萄糖基的方法,这可能会被证明有利于开发新型抗结核药物。
  • Synthesis and Characterization of<i>N</i>-glucosylated 1,3,4-Thiadiazolidines
    作者:Avinash G. Ulhe、Snehal A. Chavan、Baliram N. Berad
    DOI:10.1080/10426507.2014.938743
    日期:2015.2
    A method is presented for the synthesis of 2-tetra-O-acetyl-beta-d-glucopyran-break;osylimino-5-(aryl)imino-1,3,4-thiadiazolidines by the interaction of substituted aryl thiosemicarbazide with peracetylated glucosyl isocyanodichloride to afford N-glucosylated 5-membered 1,3,4-thiadiazolidines and their alternative synthesis by different route involving the interaction of 4-tetra-O-acetyl-beta-d-glucopyranosyl thiosemicarbazide and aryl imino isocyanodichlorides. The structures of newly synthesized compounds were confirmed by IR, H-1 NMR, C-13 NMR, and mass spectrometric analyses.
  • Synthesis and Anticancer Activity of Bis-(<i>N</i>-Glucosylated Triazolothiadiazolyl) Alkanes via Cyclocondensation Reaction Involving C–s and C–n Bond formation
    作者:Snehal A. Chavan、Avinash G. Ulhe、Spruha A. Gharad、Baliram N. Berad
    DOI:10.1080/10426507.2015.1083570
    日期:2015.12.2
    A series of bis-(4-amino-5-mercapto-1,2,4-triazol-3-yl) alkanes have been synthesized and were condensed with N-tetra-O-acetyl--D-glucopyranosyl isocyanodichloride to afford biologically active bis-[6-tetra-O-acetyl--D-glucopyranosylimino-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazol-4-yl] alkanes. The structures of the new glucosylated heterocyclic compounds have been established by IR, H-1 NMR, and C-13 NMR spectroscopy, and mass spectrometry analyses. Among the synthesized compounds, a few target compounds were screened for their in vitroanticancer activity against two human cancer cell lines, viz. MCF-7 (Breast) and HEPG2 (Liver).
  • HASSEL, T.;MUELLER, H. P.;BOESHAGEN, H.
    作者:HASSEL, T.、MUELLER, H. P.、BOESHAGEN, H.
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸